Tellgen Successfully Installed Automated Multiplexed Bead Immunoassay Analyzer TESMI F4000 at Renji Hospital


Tellgen has successfully installed the Automated Multiplexed Bead Immunoassay Analyzer TESMI F4000 at Renji Hospital, Shanghai Jiaotong University School of Medicine, the Top 3rd hospital in China; with the multiplexed suspension array technology, hospitals can advance assay efficiency and service quality.

Among all hospital reputation ranking in China, Renji Hospital ranks top 3. And in the Nature Index annual tables of 2022 published by Springer Nature, Renji Hospitals ranks top 1 in China and top 22 in the world for its indicator of institutional research performance ( with the metrics of Count and Share used to order Nature Index listings based on an institution’s or country’s publication output in 82 natural-science journals, selected on the reputation by an independent panel of leading scientists in their fields). Rheumatology and Immunology Department at Renji Hospital is also one of the most reputed for autoimmune diseases.

Multiplexed suspension array technology is the leading steam for world autoimmune disease detection, with its quantitative assay perfectly matching the needs of patients and institutions. Now it is applied in Renji Hospital. Tellgen Corporation is always dedicated to offering better solutions for global healthcare and laboratory automation, gaining a high reputation in the field of in vitro diagnostics. Tellgen has developed various comprehensive assay combinations for autoimmune detection, and many more are under development, pumping the autoimmune IVD industry to a new era.